NCM
AGN

Nelson Capital Management’s Allergan plc AGN Stock Holding History

Nelson Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-150
Closed -$25K – 312
2019
Q3 		$25K Buy
150
+60
+67% +$9.78K 0.01% 195
2019
Q2 		$15K Sell
90
-24,850
-100% -$3.44M ﹤0.01% 214
2019
Q1 		$3.65M Buy
24,940
+2,820
+13% +$409K 0.91% 42
2018
Q4 		$2.96M Sell
22,120
-15,021
-40% -$2.46M 0.82% 45
2018
Q3 		$7.08M Buy
37,141
+1,230
+3% +$226K 1.63% 22
2018
Q2 		$5.99M Sell
35,911
-130
-0.4% -$20.9K 1.54% 23
2018
Q1 		$6.07M Buy
36,041
+22,423
+165% +$3.76M 1.57% 22
2017
Q4 		$2.23M Sell
13,618
-3,808
-22% -$683K 0.69% 47
2017
Q3 		$3.57M Buy
17,426
+130
+0.8% +$30.2K 1.18% 42
2017
Q2 		$4.2M Sell
17,296
-120
-0.7% -$28.2K 1.42% 37
2017
Q1 		$4.16M Buy
17,416
+270
+2% +$62.9K 1.4% 39
2016
Q4 		$3.6M Buy
+17,146
New +$3.55M 1.26% 39

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Nelson Capital Management's AGN Position: Q4 2019 in Review

Nelson Capital Management sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 150 shares — an estimated $25K sold.

Nelson Capital Management first reported a position in AGN in Q4 2016 and held it in 12 quarters. The position peaked at $7.08M in Q3 2018. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Nelson Capital Management reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Nelson Capital Management sold 150 Allergan plc shares in Q4 2019, an estimated $25K.
  • Nelson Capital Management first reported a position in Allergan plc in Q4 2016 and held it in 12 quarters.
  • Nelson Capital Management's Allergan plc position peaked at $7.08M in Q3 2018.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Nelson Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.